BioAdaptives, Inc. Announces National Launch of NeuroRush(TM) Nootropic in 2025

BioAdaptives, Inc. (OTC Pink: BDPT) has announced the national launch of NeuroRush(TM), its innovative nootropic supplement, scheduled for late summer 2025. This next-generation product is designed to improve mental clarity, cognitive endurance, and stress adaptability, catering to the growing demand for natural cognitive enhancers. NeuroRush(TM) will be available in two formulations: one with natural caffeine and a caffeine-free option, both featuring clinically studied ingredients such as Rhodiola, Ashwagandha, and Bacopa.

The decision to roll out NeuroRush(TM) nationally follows positive feedback from test markets, indicating a strong consumer interest in adaptogen-based nootropics that support brain health without the adverse effects commonly associated with stimulants. The product's launch is poised to make a significant impact on the wellness industry, offering a natural alternative for individuals seeking to enhance their cognitive performance and manage stress more effectively.

NeuroRush(TM) will be accessible online and through select wellness partners, broadening its reach to a wide audience. This launch represents a pivotal moment for BioAdaptives, Inc. as it continues to innovate within the health and wellness sector, leveraging natural ingredients and scientific research to improve quality of life.